对乙酰普鲁卡因胺感兴趣的理论基础以及这种新型抗心律失常药物的临床经验。
Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent.
作者信息
Drayer D, Kluger J, Reidenberg M, Lahita R
出版信息
Drug Metab Rev. 1979;10(2):239-46. doi: 10.3109/03602537908997471.
PMID:95247
Abstract
In conclusion, it was the differential responses of slow and rapid acetylators to procainamide therapy that gave the initial clues that acetylprocainamide might be a safer drug than procainamide. So far, the experience with acetylprocainamide has been encouraging.
摘要
总之，正是慢乙酰化者和快乙酰化者对普鲁卡因胺治疗的不同反应，最初提示乙酰普鲁卡因胺可能是一种比普鲁卡因胺更安全的药物。到目前为止，使用乙酰普鲁卡因胺的经验一直令人鼓舞。
Zotero 插件